Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-05-05 @ 1:54 PM
Study NCT ID:
NCT07454018
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-06
First Post:
2026-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2026146
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None